Quantifying iron content in magnetic resonance imaging

Category: Papers
Related Topics: HP Phase, qsm, R2* Map, sFLAIR, swi, T1W, T2* Map, T2*W, tSWI

Author(s): Kiarash Ghassaban a , Saifeng Liu b , Caihong Jiang c , E. Mark Haacke a,b,d,*
Journal: NeuroImage
Published: 2019
Read Full Paper: https://www.sciencedirect.com/science/article/abs/pii/S1053811918303574

Abstract

Measuring iron content has practical clinical indications in the study of diseases such as Parkinson’s disease, Huntington’s disease, ferritinopathies and multiple sclerosis as well as in the quantification of iron content in microbleeds and oxygen saturation in veins. In this work, we review the basic concepts behind imaging iron using T2, T2*, T2′, phase and quantitative susceptibility mapping in the human brain, liver and heart, followed by the applications of in vivo iron quantification in neurodegenerative diseases, iron tagged cells and ultra-small superparamagnetic iron oxide (USPIO) nanoparticles.

New & Related

All Resources

Editorial: Quantitative Susceptibility Mapping in Neurodegeneration

Editorial: Quantitative Susceptibility Mapping in Neurodegeneration

The purpose of this study was to evaluate the effect of resolution on iron content using quantitative susceptibility mapping (QSM); to verify the consistency of QSM across field strengths and manufacturers in evaluating the iron content of deep gray matter (DGM) of the human brain using subjects from multiple sites; and to establish a susceptibility baseline as a function of age for each DGM structure using both a global and regional iron analysis.

read more
Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study

Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study

The purpose of this study was to evaluate the effect of resolution on iron content using quantitative susceptibility mapping (QSM); to verify the consistency of QSM across field strengths and manufacturers in evaluating the iron content of deep gray matter (DGM) of the human brain using subjects from multiple sites; and to establish a susceptibility baseline as a function of age for each DGM structure using both a global and regional iron analysis.

read more